An electrocatalyst electrode and a process for its preparation

IN595458BActive Publication Date: 2026-07-15SRM INST OF SCI & TECH
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
IN202441002915
Authority / Receiving Office
IN · IN
Patent Type
Patents
Current Assignee / Owner
Filing Date
2024-01-15
Publication Date
2026-07-15
Estimated Expiration
2044-01-15

AI Technical Summary

Technical Problem

Existing electrochemical sensors for detecting chloramphenicol in water sources are limited by complex manufacturing processes, toxicity, stability issues, and high costs, making them unsuitable for quick and real-time analysis.

Method used

A metal-organic framework modified with graphene oxide is used to create an electrocatalyst electrode, which is coupled with a glassy carbon electrode, offering a sensitive and selective detection method with a broad linear range and low detection limit, and is fabricated using a simple and scalable process.

Benefits of technology

The electrocatalyst electrode provides highly sensitive and selective detection of chloramphenicol with a low detection limit of 76.97nM and good recovery percentages in real water samples, overcoming the limitations of existing sensors with improved stability and cost-effectiveness.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

ABSTRACT AN ELECTROCATALYST ELECTRODE AND A PROCESS FOR ITS PREPARATION The present disclosure relates to an electrocatalyst electrode and a process for its preparation. The electrocatalyst electrode for the detection of a pharmaceutical contaminant(s) in water sources, the electrode comprises an electrocatalyst coupled to a glassy carbon electrode (GCE). The electrocatalyst electrode is highly selective and sensitive toward the detection of chloramphenicol antibiotics and has high water stability. The process of the present disclosure is economical, eco-friendly, and simple to perform.
Need to check novelty before this filing date? Find Prior Art

Description

FIELDThe present disclosure relates to chemical or bio-chemical sensor systems. Particularly, the present disclosure relates to an electrocatalyst electrode and a process for its preparation.DEFINITIONS As used in the present disclosure, the following terms are generally intended to have the meaning as set forth below, except to the extent that the context in which they are used indicates otherwise.The term "Metal-organic frameworks (MOFs)" refers to a class of porous, crystalline materials composed of metal ions and clusters that act as the joints, bound by multidirectional organic ligands, which act as linkers in the network structure.BACKGROUNDThe background information herein below relates to the present disclosure but is not necessarily prior art.There is a massive hike in the production of antibiotics that are employed against various bacterial infections that cause disturbances in the health of humans and animals leading to enormous usage and improper disposal. This, in turn, affects the ecology and environment through the accumulation of antibiotic residues in various water sources. For example, chloramphenicol (CAP) is an antibiotic with extensive activity against both Gram-negative and -positive bacteria. It is used for several minor and major treatments such as infections in eyes, and wounds, as well as for the treatment of cystic fibrosis, conjunctivitis, meningitis, cholera, typhoid fever, plague, and different respiratory and nervous systems infections. The CAP is also widely utilized in veterinary medicines and aquaculture.The enormous usage and improper disposal of chloramphenicol (CAP) lead to its accumulation in common water sources and its adverse effects on human beings likeaplastic anaemia, leukaemia, neurotoxic responses, bone marrow suppression, and gray baby syndrome. Therefore, selective and sensitive detection of the chloramphenicol antibiotic present in various water sources is necessary.Conventionally, different chromatographic methods, such as High-Performance liquid chromatography (HPLC), gas chromatography (GC), Liquid Chromatography-Mass Spectrometry (LC-MS), GC-MS and optical methods using surface plasmon resonance and fluorescence have been performed for the CAP detection. Nonetheless, the bulk instrumentation setup and complex and time-consuming analytical procedures restrict these methods for quick and real-time analysis. The electroanalytical methods, on the contrary, have the advantages of rapid analysis, high sensitivity, easy device fabrication, and low cost. Several electrochemical sensors were also developed for the detection of chloramphenicol. However, the complex manufacturing process, the toxic nature of the material, and the stability issue with water limit the existing electrochemical sensors.There is, therefore, a need to provide an electrocatalyst electrode and a process for its preparation that overcomes the above-mentioned drawbacks, or at least provides an alternative solution.OBJECTSSome of the objects of the present disclosure, which at least one embodiment herein satisfies, are as follows:An object of the present disclosure is to ameliorate one or more problems of the background or to at least provide a useful solution.Another object of the present disclosure is to provide an electrocatalyst electrode that is highly selective and sensitive toward the detection of broad-spectrum antibiotics, specifically an organochlorine compound.Another object of the present disclosure is to provide an electrocatalyst electrode that is highly selective and sensitive toward the detection of chloramphenicol antibiotics present in various water sources.Still another object of the present disclosure is to provide an electrocatalyst electrode that uses non-toxic metallic material, is easily fabricated, and has high water stability. Yet another object of the present disclosure is to provide an electrocatalyst electrode that has a broad linear range and a low detection limit for the detection of pharmaceutical contaminant(s).Still another object of the present disclosure is to provide an electrocatalyst electrode for sensing chloramphenicol with good recovery percentages of the analytical method in real water samples.Still another object of the present disclosure is to provide an economical electrocatalyst electrode, which is environment-friendly.Another object of the present disclosure is to provide a process for the preparation of an electrocatalyst electrode. Yet another object of the present disclosure is to provide a process for the preparation of an electrocatalyst electrode that is commercially scalable and easy to perform.Still another object of the present disclosure is to provide a simple and cost-effective process for the preparation of an electrocatalyst electrode.Another object of the present disclosure is to provide a process for the decontamination of water from pharmaceutical contaminants using an electrocatalyst electrode.Other objects and advantages of the present disclosure will be more apparent from the following description, which is not intended to limit the scope of the present disclosure.SUMMARYThe present disclosure relates to an electrocatalyst electrode for the detection of a pharmaceutical contaminant(s) in water sources, the electrocatalyst electrode comprises an electrocatalyst coupled to a glassy carbon electrode (GCE), Characterized in that, the electrocatalyst electrode exhibits a current response towards the voltammetric detection of the pharmaceutical contaminant(s) in a wide linear range from 1 to 1000μM with a low detection limit of 76.97nM.In accordance with the embodiment of the present disclosure, the electrocatalyst comprises essentially a metal-organic framework modified with a carbon support, wherein the carbon support is graphene oxide with a reduced oxygen-carbon ratio. In accordance with the embodiment of the present disclosure, the pharmaceutical contaminant is a broad-spectrum antibiotic, specifically an organochlorine compound such as chloramphenicol (CAP).In accordance with the embodiment of the present disclosure, the metal-organic framework is a crystalline porous material composed of the self-assembly of metal ions and an organic linker.In accordance with the embodiment of the present disclosure, the metal ions in the metal-organic framework is at least one selected from Aluminium, Iron, Nickel, Cobalt and Copper; and the organic linker is at least one selected from 2,6-Naphthalene dicarboxylic acid, benzene dicarboxylic acid, benzene tricarboxylic acid, methyl imidazole. The present disclosure also provides a process for the preparation of an electrocatalyst electrode. In the process, a predetermined concentration of graphene oxide is added in a first fluid medium for a first predetermined time and ultrasonicated to obtain a first solution. Further, a predetermined concentration of a second fluid medium and a predetermined concentration of a third fluid medium are added in a first fluid medium and ultrasonicated to obtain a second solution. Then the first solution and the secondsolution are mixed together and dried at a first predetermined temperature for a second predetermined time to obtain a reaction mass. Thereafter, the reaction mass is filtered, followed by washing with a first fluid medium to obtain a cleaned reaction mass. The cleaned reaction mass is dried for a second predetermined temperature to obtain an electrocatalyst. A predetermined quantity of the electrocatalyst is dispersed to a fourth fluid medium in a predetermined ratio of 0.05% w / v to obtain an electrocatalyst solution. Then the electrocatalyst solution is deposited on a glassy carbon electrode by a drop-casting method to obtain the electrocatalyst electrode.In accordance with the embodiment of the present disclosure, the first fluid medium is Dimethylformamide (DMF); the second fluid medium is at least one selected from aluminium nitrate nonahydrate or aluminium chloride; the third fluid medium is 2,6 naphthalene dicarboxylic acid; and the fourth fluid medium is at least one selected from ethanol, methanol, and acetone.In accordance with the embodiment of the present disclosure, the molar concentration of the graphene oxide is in a range of 10 mM to 30 mM, and that of the second fluid medium is in a range of 1 mM to 2 mM; and that of the third fluid medium is in a range of 0.8 mM to 1.5 mM.In accordance with the embodiment of the present disclosure, the first predetermined time is in the range of 0 to 1 hour; and the second predetermined time is in the range of 0 to 24 hours. In accordance with the embodiment of the present disclosure, the first predetermined temperature is in the range of 30°C to 130°C; and the second predetermined temperature is in the range of 70°C to 180°C.The present disclosure also provides the process for decontamination of water from pharmaceutical contaminants using an electrocatalyst electrode. In the process, an electrocatalyst electrode is prepared, and interaction with a pharmaceutical contaminant is initiated. Further, the prepared electrocatalyst electrode is characterized through X-ray diffraction, Fourier Transform Infrared (FT-IR) spectrometry, Raman spectrometry, andK-Alpha X-ray photoelectron spectroscopy, and the prepared electrocatalyst electrode is confirmed. Furthermore, the confirmed electrocatalyst electrode is tested electrochemically for sensing the pharmaceutical contaminants. Then, the electrocatalyst electrode is studied analytically and validated, followed by an electrochemical study through Cyclic voltammetry (CV), Square wave voltammetry (SWV), and electrochemical impedance spectroscopy of the tested electrocatalyst electrode to find a mechanism. Further, the interference and stability of the validated electrocatalyst electrode is studied and the studied electrocatalyst electrode is applied for the detection of the pharmaceutical contaminants in real fluid samples.In accordance with the embodiment of the present disclosure, the analytical study includes plotting calibration curves from different concentrations of antibiotics, a selectivity study, a stability test, a reproducibility study, and an application study in a real matrix.In accordance with the embodiment of the present disclosure, the mechanisms that happen at the electrocatalyst electrode are diffusion-controlled and adsorption-controlled.BRIEF DESCRIPTION OF THE ACCOMPANYING DRAWING The present disclosure will now be described with the help of the accompanying drawing, in which:Figure 1 (a): illustrates the X-ray diffraction pattern of graphene oxide (GO), reduced graphene oxide (rGO), an aluminium metal-organic framework (DUT-4), and a composite of metal-organic framework and reduced graphene oxide (DUT-4@rGO). Figure 1 (b): illustrates the Fourier Transform Infrared Spectroscopy of graphene oxide (GO), reduced graphene oxide (rGO), an aluminium metal-organic framework (DUT-4), and DUT-4@rGOFigure 1 (c): illustrates the XPS survey spectrum that shows Al2p, C 1s, and O 1s.Figure 1 (d): illustrates the Al 2p pattern in which the Al 2p peak is at 74.5 eV confirming the Al-O bonding in the metal-organic framework and the presence of Al in the +3 oxidation state.Figure 1 (e): illustrates the C 1s spectrum, which is deconvoluted into three peaks at binding energies 284.8, 286.0, 288.9 eV and that can be assigned to the C=C, C-O, and C=O bonds in the composite materials.Figure 1 (f): illustrates the O 1s spectra of DUT-4@rGO, the deconvoluted peaks at binding energies of 531.5, 532.2, and 533.4 eV of the O 1s XPS spectrum attributed to the Al-O, O-C=O, C-O bonds, respectively.Figure 2: illustrates the Field emission scanning electron microscopy of (a) DUT-4 metal-organic framework (MOF), (b) reduced graphene oxide (rGO).Figure 2 (c-d): illustrates the DUT-4 MOF@rGO at 1μm magnification and 500nm magnifications respectively.Figure 3 (a): illustrates the Cyclic Voltammograms (CVs) of bare glassy carbon electrode (GCE), rGO / GCE, DUT-4 / GCE, and DUT-4@rGO / GCE; Figure 3 (b): illustrates the Cyclic Voltammograms (CVs) of DUT-4@rGO / GCE in blank and in the presence of 0.1 mM CAP in 0.1 M PBS (pH 7.0), Scan rate: 100 mVs-1;Figure 3 (c): illustrates the Cyclic Voltammograms (CVs) of DUT-4, DUT-4@rGO, and rGO-modified GCE in 5mM K3[Fe(CN)6] solution; andFigure 3 (d): illustrates the Electrochemical impedance spectra of rGO / GCE, DUT-4 / GCE, and DUT-4@rGO / GCE performed in 5mM K3[Fe(CN)6] solution.Figure 4: illustrates the Cyclic Voltammograms (CVs) of (a) DUT-4@rGO / GCE in different supporting electrolytes and (b) different volumes of catalyst suspension drop casted on GCE;Figure 4 (c): illustrates the peak current variation with pH; andFigure 4 (d): illustrates the variation of peak potential in different pH of the electrolyte solution (0.1 M PBS).Figure 5(a): illustrates the Square wave voltammetric response for different concentrations of CAP: 0 μM - 1000 μM in 0.1 M PBS at 50 mVs-1; andFigure 5(b): illustrates the Linear calibration plot of the Square Wave Voltammetry (SWV) response for CAP.Figure 6(a): illustrates the Cyclic Voltammograms (CVs) of DUT-4@rGO / GCE in 0.1M PBS in the presence of CAP at different scan rates: 10-500 mV s-1;Figure 6(b): illustrates the Linear relationships of the log of peak current with the log of scan rate with a slope of 0.796; Figure 6(c): illustrates the Linear relationships of peak current with the square root of different scan rates; andFigure 6(d): illustrates the Linear relationships of peak current vs. scan rate.Figure 7(a): illustrates the current responses of DUT-4@rGO / GCE towards CAP and other analytes in the presence of 0.1 mM CAP; and Figure 7(b): illustrates the Cyclic Voltammogram curves of DUT-4@rGO / GCE for 30 cycles after adding 1 mM CAP solution.DETAILED DESCRIPTIONEmbodiments of the present disclosure will now be described with reference to the accompanying drawing. Embodiments are provided so as to thoroughly and fully convey the scope of the present disclosure to the person skilled in the art. Numerous details are set forth, relating to specific components, and methods, to provide a complete understanding of embodiments of the present disclosure. It will be apparent to the person skilled in the art that the detailsprovided in the embodiments should not be construed to limit the scope of the present disclosure. In some embodiments, well-known processes, well-known apparatus structures, and well-known techniques are not described in detail.The terminology used, in the present disclosure, is only for the purpose of explaining a particular embodiment and such terminology shall not be considered to limit the scope of the present disclosure. As used in the present disclosure, the forms "a," "an," and "the" may be intended to include the plural forms as well, unless the context clearly suggests otherwise. The terms "comprises," "comprising," "including," and "having," are open-ended transitional phrases and therefore specify the presence of stated features, integers, steps, operations, elements, modules, units, and / or components, but do not forbid the presence or addition of one or more other features, integers, steps, operations, elements, components, and / or groups thereof. The particular order of steps disclosed in the method and process of the present disclosure is not to be construed as necessarily requiring their performance as described or illustrated. It is also to be understood that additional or alternative steps may be employed. As used herein, the term "and / or" includes any and all combinations of one or more of the associated listed elements.The terms first, second, third, etc., should not be construed to limit the scope of the present disclosure as the aforementioned terms may be only used to distinguish one element, component, region, layer, or section from another component, region, layer, or section. Terms such as first, second, third, etc., when used herein do not imply a specific sequence or order unless clearly suggested by the present disclosure.There is a massive hike in the production of antibiotics that are employed against various bacterial infections that cause disturbances in the health of humans and animals leading to enormous usage and improper disposal. This, in turn, affects the ecology and environment through the accumulation of antibiotic residues in various water sources. For example, chloramphenicol (CAP) is an antibiotic with extensive activity against both Gram-negative and -positive bacteria. It is used for several minor and major treatmentssuch as infections in eyes, and wounds, as well as for the treatment of cystic fibrosis, conjunctivitis, meningitis, cholera, typhoid fever, plague, and different respiratory and nervous systems infections. The CAP is also widely utilized in veterinary medicines and aquaculture.The enormous usage and improper disposal of chloramphenicol (CAP) lead to its accumulation in common water sources and its adverse effects on human beings like aplastic anaemia, leukaemia, neurotoxic responses, bone marrow suppression, and gray baby syndrome. Therefore, selective and sensitive detection of the chloramphenicol antibiotic present in various water sources is necessary.Conventionally, different chromatographic methods, such as High-Performance liquid chromatography (HPLC), gas chromatography (GC), Liquid Chromatography-Mass Spectrometry (LC-MS), GC-MS and optical methods using surface plasmon resonance and fluorescence have been performed for the CAP detection. Nonetheless, the bulk instrumentation setup and complex and time-consuming analytical procedures restrict these methods for quick and real-time analysis. The electroanalytical methods, on the contrary, have the advantages of rapid analysis, high sensitivity, easy device fabrication, and low cost. Several electrochemical sensors were also developed for the detection of chloramphenicol. However, the complex manufacturing process, the toxic nature of the material, and the stability issue with water limit the existing electrochemical sensorsThe present disclosure provides an electrocatalyst electrode and a process for its preparation.In an aspect, the present disclosure relates to an electrocatalyst electrode for the detection of a pharmaceutical contaminant(s) in water sources. The electrocatalyst electrode comprises an electrocatalyst coupled to a glassy carbon electrode (GCE), characterized in that the electrocatalyst electrode exhibits a current response towards the voltammetric detection of the pharmaceutical contaminant(s) in a wide linear range from 1 to 1000μM with a low detection limit of 76.97nM.In accordance with the embodiment of the present disclosure, the electrocatalyst comprises essentially a metal-organic framework modified with carbon support, wherein said carbon support is graphene oxide with a reduced number oxygen-carbon ratio.In accordance with the embodiment of the present disclosure, the pharmaceutical contaminant is a broad-spectrum antibiotic, specifically an organochlorine compound. In an exemplary embodiment, the organochlorine compound is chloramphenicol (CAP) and the electrocatalyst electrode is used to detect the presence of CAP in a water source.In an exemplary embodiment, the water sources include, but are not limited to lake water tap water, and the like.In accordance with the embodiment of the present disclosure, the metal-organic framework is a crystalline porous material composed of the self-assembly of metal ions and the organic linker.In accordance with the embodiment of the present disclosure, the metal ions in the metal-organic framework is Aluminium. In an alternative embodiment, the metal ions can also be selected from Iron, Copper, Cobalt, Zinc, and Nickel. In an embodiment, the organic linker is selected from 2,6-Naphthalene dicarboxylic acid, benzene tricarboxylic acid, benzene dicarboxylic acid, 2-methyl imidazole, and the like. In a preferred embodiment, for the formation of an electrocatalyst the used organic linker is 2,6-Naphthalene dicarboxylic acid.In another aspect, the present disclosure provides a process for the preparation of an electrocatalyst electrode. In the process, a predetermined concentration of graphene oxide is added in a first fluid medium for a first predetermined time and ultrasonicated to obtain the first solution. Further, a predetermined concentration of a second fluid medium and a predetermined concentration of a third fluid medium are added in a first fluid medium and ultrasonicated to obtain a second solution. Then the first solution and the second solution are mixed together and dried at a first predetermined temperature for a secondpredetermined time to obtain a reaction mass. Thereafter, the reaction mass is filtered, followed by washing with a first fluid medium to obtain a cleaned reaction mass. The cleaned reaction mass is dried for a second predetermined temperature to obtain an electrocatalyst. A predetermined quantity of the electrocatalyst is dispersed to a fourth fluid medium in a predetermined ratio of 0.05% w / v to obtain an electrocatalyst solution. Then the electrocatalyst solution is deposited on a glassy carbon electrode by a drop-casting method to obtain the electrocatalyst electrode.In the first step, a predetermined concentration of graphene oxide is added in a first fluid medium for a first predetermined time and ultrasonicated to obtain a first solution.In accordance with the embodiments of the present disclosure, the predetermined concentration of graphene oxide is in the range of 10 mM to 30 mM and the first fluid medium is Dimethylformamide (DMF). The graphene oxide is collected having a weight of 260 gm and dissolved in 10 ml of Dimethylformamide (DMF) for 1 hour and is ultrasonicated to obtain the first solution.In the second step, a predetermined concentration of a second fluid medium and a predetermined concentration of a third fluid medium may be added to the first fluid medium and ultrasonicated to obtain a second solution.In accordance with the embodiments of the present disclosure, the second fluid is at least one selected from aluminium nitrate nonahydrate or aluminium chloride, and the third fluid is 2, 6 naphthalene dicarboxylic acid. In an exemplary embodiment, the aluminium nitrate nonahydrate has a concentration in the range of 1mM to 2 mM, and the 2,6 naphthalene dicarboxylic acid having a concentration in the range of 0.8 mM to 1.5 mM is dissolved together in 20 ml of Dimethylformamide and ultrasonicated to obtain a second solution.In a third step, the first solution and the second solution may be mixed and dried at a first predetermined temperature for a second predetermined time to obtain a reaction mass.In accordance with the embodiments of the present disclosure, the first solution and the second solution both be mixed properly and kept for heating at 130°C in a muffle furnace for 24 hours to dry the reaction mass and in order to obtain a reaction mass. In an exemplary embodiment, the reaction mass is a grey powder.In accordance with the present disclosure, the first predetermined temperature is in the range of 30°C to 130°C. In a preferred exemplary embodiment, the first predetermined temperature is 130°C.In accordance with the present disclosure, the first predetermined time period is in the range of 0.5 hours to 1 hour. In a preferred exemplary embodiment, the first predetermined time is 1 hour. The second predetermined time period is in the range of 0 hours to 24 hours. In a preferred exemplary embodiment, the second predetermined time is 24 hours.In the fourth step, the reaction mass may be filtered and washed with the first fluid medium to obtain the cleaned reaction mass.In accordance with the present disclosure, the reaction mass is filtered, followed by being washed with dimethylformamide three times to obtain the cleaned reaction mass.In the fifth step, the cleaned reaction mass is dried for a second predetermined temperature to obtain a metal catalyst.In accordance with the embodiments of the present disclosure, the cleaned reaction mass is heated at 180°C in an oven to dry the cleaned reaction mass and in order to obtain the electrocatalyst.In accordance with the embodiments of the present disclosure, the second predetermined temperature is in the range of 70°C to 180°C. In a preferred exemplary embodiment, the first predetermined temperature is 180°C.In the sixth step, a predetermined quantity of the electrocatalyst is dispersed to a fourth fluid medium in a predetermined ratio of 0.05 w / v to obtain an electrocatalyst solution.In an exemplary embodiment of the present disclosure, 1 mg of electrocatalyst is collected and dissolved in 0.5 ml of ethanol to prepare the electrocatalyst solution.In accordance with the embodiments of the present disclosure, the first fluid medium is Dimethylformamide (DMF); the second fluid medium is at least one selected from aluminium nitrate nonahydrate or aluminum chloride; the third fluid medium is 2,6 naphthalene dicarboxylic acid; and the fourth fluid medium is at least one selected from ethanol, methanol, acetone, and the likes.In the seventh step, the electrocatalyst solution is deposited to the glassy carbon electrode (GCE) by using a drop-casting method to obtain the electrocatalyst electrode.In an exemplary embodiment, the electrocatalyst is denoted as DUT-4@rGo, and the solution of the electrocatalyst is deposited on a glassy carbon electrode to prepare the electrocatalyst electrode (DUT-4@rGO / GCE).The prepared electrocatalyst electrode is then used for measuring the current corresponding to the reduction of chloramphenicol.The electrocatalyst and the modification as an electrocatalyst electrode of the present disclosure have numerous advantages such as the electrocatalyst (DUT-4@rGO) is very highly sensitive and selective toward the detection of chloramphenicol antibiotics present in various water sources. The modified electrocatalyst electrode (DUT-4@rGO / GCE) showed better selectivity, stability, and repeatability toward CAP sensing. DUT-4@rGO / GCE was tested in real water samples including lake water and tap water with a good recovery. The electrocatalysts show a highly sensitive performance with a broad linear range of 1-1000 μM of CAP and a low detection limit of 76.97nM. The easy fabrication, non-toxic nature of the material used, and high water stability of the DUT-4@rGO sensor give an advantage over the other existing electrochemical sensors.The metal-organic framework (MOF) is composed of crystalline porous material. Further, the crystalline materials are composed of metal-ions and clusters which act as the joints, bound by multidirectional organic ligands, which act as organic linkers; and the grapheneoxide is reduced graphene oxide (rGO). The reduced graphene oxide is derived from the graphene oxide by chemical and thermal methods to reduce the content of carbon and is less dispersible in water and other solvents as compared to the graphene oxide. Therefore, to develop the electrocatalyst, reduced graphene oxide is preferred.In an exemplary embodiment, an aluminium metal-organic framework (Al MOF) is used for the preparation of the electrocatalyst. The aluminium metal-organic framework is also known as "DUT-4" which is developed by using the self-assembly of metal ions and the organic linker and by the method of facile solvothermal method. The easy fabrication, non-toxic nature of the material used, and high water stability of the aluminium metal-organic framework gives an advantage to the electrocatalyst as compared to the conventionally available electrochemical sensors.The aluminium metal-organic framework is synthesized by a facile solvothermal method and the reduced graphene oxide is incorporated in situ by one-spot synthesis to enhance its electrocatalytic activity. The prepared electrocatalyst is denoted as DUT-4@rGO. The electrocatalyst (DUT-4@rGo) is very highly sensitive and selective toward the detection of the pharmaceutical contaminant(s).In an exemplary embodiment, the pharmaceutical contaminant is a broad-spectrum antibiotic, specifically an organochlorine compound such as chloramphenicol (CAP). Therefore, the DUT-4@rGo is very highly sensitive and selective toward the detection of the chloramphenicol antibiotic present in the various water sources. The electrocatalyst also possesses a broad linear range and low detection rate of chloramphenicol antibiotic.In accordance with the embodiments of the present disclosure, the electrocatalyst is modified by coupling with a glassy carbon electrode (GCE). The DUT-4@rGO is fabricated on a glassy carbon electrode by a simple drop-casting method to develop an electrocatalyst electrode. the electrocatalyst electrode is denoted as (DUT-4@rGO / GCE). The electrocatalyst electrode (DUT-4@rGO / GCE) is tested in real samples including lake water and tap water with a good recovery.In the present disclosure, a highly sensitive and selective electrocatalyst electrode is developed for the detection of chloramphenicol (CAP) in various water sources and it is developed by a facile solvothermal approach. The electrochemical behavior of DUT-4 MOF is studied towards the detection of chloramphenicol and it is observed that the in-situ incorporation of rGO by a one-spot synthesis facilitates better electron transport across the electrode-electrolyte interface. The fabricated electrocatalyst exhibits a highly sensitive performance with a broad linear range of 1 - 1000 μM of CAP and a low detection limit of 76.97nM.In yet another aspect, the present disclosure relates to a process for decontamination of water from pharmaceutical contaminants using an electrocatalyst electrode. In the process, an electrocatalyst electrode is prepared, and interaction with a pharmaceutical contaminant is initiated. Further, the prepared electrocatalyst electrode is characterized through X-ray diffraction, Fourier Transform Infrared (FT-IR) spectrometry, Raman spectrometry, and K-Alpha X-ray photoelectron spectroscopy, and the prepared electrocatalyst electrode is confirmed. Furthermore, the confirmed electrocatalyst electrode is tested electrochemically for sensing the pharmaceutical contaminants. Then, the electrocatalyst electrode is studied analytically and validated, followed by an electrochemical study through Cyclic voltammetry (CV), Square wave voltammetry (SWV), and electrochemical impedance spectroscopy of the tested electrocatalyst electrode to find a mechanism. Further, the interference and stability of the validated electrocatalyst electrode is studied and the studied electrocatalyst electrode is applied for the detection of the pharmaceutical contaminants in real fluid samples.The electrocatalyst in accordance with the present disclosure shows excellent stability, selectivity, and reproducibility. Conventionally, different chromatographic methods, such as High-Performance liquid chromatography (HPLC), gas chromatography (GC), Liquid Chromatography-Mass Spectrometry (LC-MS), GC-MS and optical methods using surface plasmon resonance and fluorescence have been performed for CAP detection. Nonetheless, the bulk instrumentation setup and complex and time-consuming analytical procedures restrict these methods for quick and real-time analysis. The electroanalyticalmethods, on the contrary, have the advantages of rapid analysis, high sensitivity, easy device fabrication, and low cost. Several electrochemical sensors have been developed for the detection of chloramphenicol. However, the easy fabrication, non-toxic nature of the material used, and high water stability of the Al MOF give advantages to the electrocatalyst (DUT-4@rGO) compared with the other existing electrochemical sensors. In accordance with the embodiment of the present disclosure, the analytical study includes plotting calibration curves from different concentrations of antibiotics, a selectivity study, a stability test, a reproducibility study, and an application study in a real matrix.In accordance with the embodiment of the present disclosure, the electrocatalyst electrode is tested to find out the two types of mechanism, the first one is diffusion-controlled and the second one is adsorption-controlled. Both mechanisms happen at the electrocatalyst electrode, which gives the chemical equation of the electrocatalytic reduction of the chloramphenicol.In addition, DUT-4@rGO is successfully applied for sensing CAP in real samples with good recoveries, offers better performance, and can be used for viable environmental monitoring of chloramphenicol.The present disclosure is further illustrated herein below with the help of the following non-limiting examples, optionally illustrated through suitable experimental details. The examples used herein are intended merely to facilitate an understanding of ways in which the embodiments herein may be practiced and to further enable those of skill in the art to practice the embodiments herein. Accordingly, the examples should not be construed as limiting the scope of embodiments herein.EXAMPLES:Example 1:Preparation of the electrocatalyst in accordance with the present disclosure:The graphene oxide with a weight of 260 gm is collected and dissolved in 10 ml of Dimethylformamide (DMF) for 1 hour and ultrasonicated to obtain the first solution. 1.4 mM of the aluminium nitrate nonahydrate (Al(NO3)3.9H2O) and 1.2 mM of the 2,6 naphthalene dicarboxylic acid are added in 20 ml of Dimethylformamide and dissolved together using an ultrasonication to obtain a second solution. The first solution and the second solution both are mixed properly and kept for heating at 130°C in a muffle furnace for 24 hours to dry and in order to obtain a reaction mass, the reaction mass is a grey powder. The grey powder is filtered and washed with dimethylformamide three times to obtain the cleaned grey powder. The obtained cleaned grey powder is then heated at 180°C in an oven to dry and activate the cleaned grey powder. The activated grey powder composite is known as the electrocatalyst and is denoted as DUT-4@rGO.Example 2:Preparation of the electrocatalyst electrode in accordance with the present disclosure The glassy carbon electrode (GCE) is obtained. The electrocatalyst solution of the electrocatalyst and ethanol is prepared, in which 1mg of activated grey powder (DUT-4@rGO) is dissolved in 0.5 ml of ethanol to prepare the electrocatalyst solution. The prepared electrocatalyst solution is deposited on the GCE to fabricate the electrocatalyst electrode which is denoted as a DUT-4@rGO / GCE. Example 3:Experimental characterization of the electrocatalyst electrode in accordance with the present disclosureFigure 1 depicts (a) the X-ray diffraction pattern of graphene oxide (GO), reduced graphene oxide (rGO), an aluminium metal-organic framework (DUT-4), and a composite of metal-organic framework and reduced graphene oxide (DUT-4@rGO); (b)FT-IR spectra of GO, rGO, DUT-4, and DUT-4@rGO; (c) XPS survey spectrum; (d) Al 2p; (e) C 1s (f) O 1s spectra of DUT-4@rGOAs depicted in Figure 1(a), The XRD patterns of GO, rGO, DUT-4, and its rGO composite are displayed in Fig. 1a. The diffraction pattern of GO showed a

[001] peak whereas its absence and emergence of a broad

[002] peak in solvothermally synthesized rGO confirms the reduction of GO. The XRD patterns of the as-synthesized MOF and DUT-4@rGO display peaks attributable to

[101] ,

[110] , and

[113] crystal facets at 2θ values 6.92º, 13.87º, and 21.01º, respectively. The MOF structure is not disturbed by the in-situ synthesis of DUT-4@rGO as evidenced by the similar XRD pattern of the prepared composite material with that of MOF. The peak broadening in the 2θ range of 20 to 30 of the modified catalyst also confirms the successful formation of the composite.Referring to Figure 1(b), the FT-IR spectra of the Graphene oxide, reduced graphene oxide, DUT-4 Aluminium MOF, DUT-4@rGO are shown in Fig. 1b. The broadband occurring between 3200 cm-1 and 3600 cm-1 of GO ascribes to the stretching and bending vibrations of OH groups present in it that are disappeared in FT-IR spectrum of rGO due to the conversion of GO to rGO. In the FT-IR spectra of DUT-4 and DUT-4@rGO, the peaks at 1693 cm-1 and 1688 cm-1 correlate with the carbonyl stretching vibrations (νc=o) of the NDC linker, which suggests effective metal coordination to the linker. The peak shift of the MOF composite towards higher energy and the decrease in the peak intensities are strong shreds of evidence for the effective interaction of DUT-4 with rGO. Referring to Figure 1(c), XPS is further employed to determine the chemical composition of the prepared DUT-4@rGO. From the XPS survey spectrum, as depicted in Fig. 1c, the presence of aluminium, carbon, and oxygen elements has been confirmed.As shown in Figure 1(d), The Al 2p peak at 74.5 eV confirms the Al-O bonding in the metal-organic framework and the presence of Al in the +3 oxidation state.Figure 2 depicts the crystalline structure of the DUT-4 MOF, the Field emission scanning electron microscopy of (a) DUT-4 metal-organic framework (MOF), (b) reduced graphene oxide (rGO), (c) and (d) DUT-4 MOF@rGO at different magnificationsAs depicted in Figure 2(a), The FE-SEM images of the pristine DUT-4 MOF, reduced graphene oxide sheets, and DUT-4@rGO were taken by coating ethanol dispersions of each material in a Cu foil and given in Fig. 2(a-d). The synthesized DUT-4 MOF has a flake-like morphology as depicted in Fig. 2a. It is well evident from Fig. 2 (c,d), that these MOF particles are evenly distributed on the rGO sheets.Figure 3. (a-c) depicts the cyclic voltammograms (CVs). Figure 3. (a) depicts the CVs of bare GCE, rGO / GCE, DUT-4 / GCE, and DUT-4@rGO / GCE; Figure 3. (b) depicts the CVs of DUT-4@rGO / GCE in blank and in presence of 0.1 mM CAP in 0.1 M PBS (pH 7.0), Scan rate: 100 mV s-1; Figure 3 (c) depicts the CVs of DUT-4, DUT-4@rGO and rGO modified GCE in 5mM K3[Fe(CN)6] solution; Figure 3(d) depicts the Electrochemical impedance spectra of rGO / GCE, DUT-4 / GCE and DUT-4@rGO / GCE performed in 5mM K3[Fe(CN)6] solution. The nature of the electrochemical performance of CAP on bare GCE, rGO, DUT-4 MOF, and DUT-4@rGO modified GCE is investigated in 0.1 M PBS solution containing 100μM CAP using Cyclic Voltammetry (CV) experiments. A single reduction peak was seen on bare GCE, whereas a pair of distinct redox peaks and a reduction peak appeared on the other modified electrodes among which the electrocatalyst electrode (DUT-4@rGO / GCE) showed enhanced current intensity and well-defined redox peaks as depicted in Figure 3(a). rGO / GCE doesn't give sharp peaks for CAP but exhibited a broad CV due to the capacitive currents. The irreversible reduction peak at -0.58 V is credited for the conversion of CAP to its aryl hydroxyl amine derivative. The reversible peaks of oxidation and reduction at -0.05 V and -0.09 V can be ascribed to the redox behavior between the aryl hydroxylamine and nitroso derivatives of CAP. Moreover, there are no significant catalytic peaks for the DUT-4@rGO modified GCE in the absence of an analyte as depicted in Figure 3(b). The cathodic peak shift to the positive potential andthe shift of anodic peak current to negative potentials better confirm the effective modification of GCE and enhanced electron transport of CAP.To compare the charge transfer resistance on the modified DUT-4@rGO / GCE electrodes, the Electrochemical Impedance Spectroscopy (EIS) technique has been performed for the fabricated electrodes in a mixed electrolyte solution of Ferri-Ferro cyanide (5 mM) and KCl (0.1 M) as depicted in Figure 3(c). From the Nyquist plots obtained, it was observed that the smaller semicircle curve for DUT-4@rGO / GCE compared with the bare and DUT-4 / GCE electrodes suggesting its lower charge transfer resistance. The calculated ESA for rGO / GCE, DUT-4 / GCE, and DUT-4@rGO / GCE were 0.216 cm2, 0.096 cm2 and 0.115 cm2 respectively. The integration of rGO effectively enhanced the electroactive surface area in DUT-4@rGO-modified GCE.Referring to Figure 4, Figure 4 (a) depicts the cyclic voltammograms (CVs) of DUT-4@rGO / GCE in different supporting electrolytes; Figure 4 (b) depicts the CVs of different volumes of catalyst suspension drop cast on GCE; Figure 4 (c) depicts the peak current variation with pH; and Figure 4 (d) depicts the variation of peak potential in different pH of the electrolyte solution (0.1 M PBS)Based on the voltammograms, PBS electrolyte with a pH of 7 was found to be appropriate for CAP detection and was used throughout the experimental study.Example 4:Electrochemical Detection of Chloramphenicol (CAP) as an exemplary embodiment:The DUT-4@rGO / GCE is tested in real samples including lake water and tap water with a good recovery and measuring the current corresponding to the reduction of chloramphenicol.Figure 5(a) depicts the Square wave voltammetric (SWV) response for different concentrations of CAP: 0 μM - 1000 μM in 0.1 M PBS at 50 mVs-1; Figure 5 (b) depicts the Linear calibration plot of SWV response for CAPIt is observed that the cathodic current varies linearly with the CAP concentrations in two wide linear ranges from 1 μM to 200 μM and from 200 μM to 1000 μM (Figure 5(b)). The existence of two linear ranges is possibly due to the surface assimilation of the analyte on the modified electrocatalyst electrode after adding certain concentrations of CAP. The two linear ranges followed these regression equations: Ipc = -0.3375 CCAP - 135.825 [R2=0.99] for concentrations of CAP ranging from 1 μM to 200 μM and Ipc = -0.0701 CCAP - 182.977 [R2=0.98] for concentrations of CAP ranging 200 μM to 1000 μM. The Limit of Detection (LOD) was calculated from the formula 3σ / S, where σ is the standard deviation obtained from the replicate measurements of the lowest concentration and S is the slope of the calibration curve. A very low LOD value of 76.97 nM was obtained from the SWV calibration plot with an excellent sensitivity value of 4753.94 μA mM-1 cm-2. Figure 6 depicts the CVs of DUT-4@rGO / GCE in 0.1M PBS in the presence of CAP at different scan rates: 10-500 mV s-1; Figure 6 (b-d) depicts the Linear relationships of peak current and scan rate; Figure 6 (b) depicts the log of peak current with log of scan rate; figure 6 (c) depicts the peak current with the square root of different scan rates; figure 6 (d) peak current vs scan rate. Scan rates were varied from 10 to 500 mV s-1 to study the nature of the reaction on the DUT-4@rGO sensor surface in the presence of the analyte as depicted in Figure 6 (a). Also, the graph of the cathodic peak against the square root of the scan rate as depicted in Figure 6 (c) shows a well-linear behavior, Ip = 190.602 ʋ1 / 2 - 21.485 (R2 = 0.99) indicating the possibility of diffusion-controlled mechanism. Also, the cathodic peak current showed good linear behavior with scan rate, and can be expressed as I (μA) = 215.367ν + 13.331 (R = 0.99) as depicted in Figure 6 (d). The linearity of the plot of scan rate with peak current shows the adsorption-controlled kinetics. From the plot ofln(current) against ln (scan rate) as depicted in Figure 6 (b) the linear regression equation is ln(Ip) = 0.796 ln(ʋ) - 8.457 (R2 = 0.99) with a slope of 0.796 which is in between the theoretical values of 0.5 for a typical diffusion controlled mechanism and 1, which is for an adsorption controlled mechanism. This indicates that both mechanisms prevail in sensing CAP suggesting mixed adsorption-diffusion kinetics. Referring to Figure 7, Figure 7(a) depicts the Current responses of DUT-4@rGO / GCE towards CAP and other analytes in the presence of 0.1 mM CAP; Figure 7 (b) depicts the CV curves of DUT-4@rGO / GCE for 30 cycles after adding 1mM CAP solution.The major anions and cations present in water and some of the other antibiotics were also studied for interference. It is observed that there is no significant current deviation for sensing CAP in the presence of 10 times higher concentrations of other ionic species. The structural analog of CAP which is Thiamphenicol (THP) also showed very little interference when present in the same ratio as that of CAP. The presence of other antibiotics like SMZ, CFX, AZT, and TC in a 1:1 ratio with CAP also showed negligible changes in the reduction peak current. This brings out the better selective nature of the fabricated electrocatalyst for CAP.The repeatability of the electrocatalyst is studied by performing CVs of 1 mM CAP for 30 cycles using the optimized electrochemical conditions. The peak current obtained from the CVs of the DUT-4@rGO / GCE electrode has been shown to endure up to 95% of the initial response even after 20 cycles (Relative Standard Deviation, RSD=2.1%) as depicted in Figure 7 (b). The stability of the electrocatalyst is validated by observing the current signals obtained for 100 μM of CAP over 30 days. Even after 30 days, the cathodic peak current obtained for the prepared electrocatalyst keeps up to 95% of its initial value (RSD = 3.64 %, n=3). The reproducibility of the proposed electrocatalyst was tested by drop casting DUT-4@rGO on four different GCEs under the optimized conditions. The RSD calculated was 4.12 % for the peak current of 100 μM CAP, which reveals the reliability of the fabrication strategy.Table 1: Table 1 depicts the Detection of CAP in tap water and lake water samples using developed DUT-4@rGO / GCEThe potential application of DUT-4@rGO / GCE on CAP sensing is investigated with the real samples collected from lake water and tap water. The samples were prepared by spiking CAP and then particular concentrations of the sample were added to the 0.1 M PBS (pH=7.4) solution. The current response for each spiked concentration matched with the points in the calibration plot and the summarized data are presented in Table 1. Notably, the recovery rates ranged from 95% to 97% for CAP in these samples and the RSDs were found to be lower than 5% indicating that the DUT-4@rGO / GCE presents itself as a promising candidate for the practical electrochemical detection of CAP. Table 1: Detection of CAP in tap water and lake water samples using developed DUT-4@rGO / GCETECHNICAL ADVANCEMENTSThe present disclosure described herein above has several technical advantages including, but not limited to, the realization of the electrocatalyst electrode, wherein the electrocatalyst electrode: - is highly selective and sensitive toward the detection of chloramphenicol antibiotics;- has a non-toxic metallic material;- is easily fabricated, and minimizes the fabrication cost;- has high water stability; - has repeatability towards chloramphenicol sensing;- has a broad linear range of chloramphenicol and a low detection limit; and- is eco-friendly and economical.Throughout this specification the word "comprise", or variations such as "comprises" or "comprising", will be understood to imply the inclusion of a stated element, integer or step, or group of elements, integers, or steps, but not the exclusion of any other element, integer or step, or group of elements, integers or steps.The use of the expression "at least" or "at least one" suggests the use of one or more elements or ingredients or quantities, as the use may be in the embodiment of the invention to achieve one or more of the desired objects or results. While certain embodiments of the inventions have been described, these embodiments have been presented by way of example only, and are not intended to limit the scope of the inventions. Variations or modifications to the formulation of this invention, within thescope of the invention, may occur to those skilled in the art upon reviewing the disclosure herein. Such variations or modifications are well within the spirit of this invention.The numerical values given for various physical parameters, dimensions, and quantities are only approximate values and it is envisaged that the values higher than the numerical value assigned to the physical parameters, dimensions, and quantities fall within the scope of the invention unless there is a statement in the specification to the contrary.While considerable emphasis has been placed herein on the specific features of the preferred embodiment, it will be appreciated that many additional features can be added and that many changes can be made in the preferred embodiment without departing from the principles of the disclosure. These and other changes in the preferred embodiment of the disclosure will be apparent to those skilled in the art from the disclosure herein, whereby it is to be distinctly understood that the foregoing descriptive matter is to be interpreted merely as illustrative of the disclosure and not as a limitation.

Claims

1. An electrocatalyst electrode for the detection of a pharmaceutical contaminant(s) in water sources, said electrocatalyst electrode comprises an electrocatalyst coupled to a glassy carbon electrode, Characterized in that: Said electrocatalyst electrode exhibits a current response towards the voltammetric detection of the pharmaceutical contaminant(s) in a wide linear range from 1 to 1000 μM with a low detection limit of 76.97 nM.

2. The electrocatalyst electrode as claimed in claim 1, wherein said electrocatalyst comprises essentially a metal-organic framework modified with a carbon support, wherein said carbon support is graphene oxide with a reduced oxygen-carbon ratio.

3. The electrocatalyst electrode as claimed in claim 1, wherein said pharmaceutical contaminant is a broad-spectrum antibiotic, specifically an organochlorine compound such as chloramphenicol (CAP).

4. The electrocatalyst electrode as claimed in claim 2, wherein said metal-organic framework is a crystalline porous material composed of self-assembly of metal ions and an organic linker.

5. The electrocatalyst electrode as claimed in claim 4, wherein said metal-ions in said metal-organic framework is selected from Aluminium, Iron, Cobalt, Nickel, and Copper; and said organic linker in said metal-organic framework is selected from 2,6-Naphthalene dicarboxylic acid, benzene dicarboxylic acid, benzene tricarboxylic acid, methyl imidazole.

6. A process for the preparation of an electrocatalyst electrode, said process comprises the steps of: a. adding a predetermined concentration of a graphene oxide in a first fluid medium for a first predetermined time and ultrasonicating to obtain a first solution; b. adding a predetermined concentration of a second fluid medium and a predetermined concentration of a third fluid medium in said first fluid medium and ultrasonicating to obtain a second solution; c. mixing said first solution and said second solution and drying at a first predetermined temperature for a second predetermined time to obtain a reaction mass; d. filtering, followed by washing said reaction mass with said first fluid medium to obtain a cleaned reaction mass; e. drying said cleaned reaction mass for a second predetermined temperature to obtain an electrocatalyst; f. dispersing a predetermined quantity of said electrocatalyst to a fourth fluid medium in a predetermined ratio of 0.05% w / v to obtain an electrocatalyst solution; and g. drop-casting said electrocatalyst solution on a glassy carbon electrode to obtain said electrocatalyst electrode.

7. The process as claimed in claim 6, wherein said first fluid medium is Dimethylformamide (DMF); said second fluid medium is selected from aluminium nitrate nonahydrate or aluminium chloride; said third fluid medium is 2,6 naphthalene dicarboxylic acid; and said fourth fluid medium is selected from ethanol, methanol, and acetone.

8. The process as claimed in claim 6, wherein said molar concentration of the graphene oxide is in a range of 10 mM to 30 mM, that of the second fluid medium is in a range of 1 mM to 2 mM; and that of the third fluid medium is in a range of 0.8 mM to 1.5 mM.

9. The process as claimed in claim 6, wherein said first predetermined time is in the range of 0 to 1 hour; and said second predetermined time is in the range of 0 to 24 hours.

10. The process as claimed in claim 6, wherein said first predetermined temperature is in the range of 30°C to 130°C; and said second predetermined temperature is in the range of 70°C to 180°C.

11. A process for decontamination of water from pharmaceutical contaminants using an electrocatalyst electrode, comprising the steps of: i. preparing said electrocatalyst electrode and initiating interaction with a pharmaceutical contaminant; ii. characterizing said prepared electrocatalyst electrode through X-ray diffraction, Fourier Transform Infrared (FT-IR) spectrometry, Raman spectrometry, and K-Alpha X-ray photoelectron spectroscopy, and confirming the preparation of said electrocatalyst electrode; iii. testing said confirmed electrocatalyst electrode electrochemically for sensing said pharmaceutical contaminants; iv. studying said electrocatalyst electrode analytically and validating, followed by electrochemical study through Cyclic voltammetry (CV), Square wave voltammetry (SWV), and electrochemical impedance spectroscopy of said tested electrocatalyst electrode to find a mechanism; v. studying interference and stability of said validated electrocatalyst electrode; and vi. applying said studied electrocatalyst electrode for detecting said pharmaceutical contaminants in real fluid samples.

12. The process as claimed in claim 11, wherein said analytical study includes plotting calibration curves from different concentrations of antibiotics, a selectivity study, a stability test, a reproducibility study, and an application study in a real matrix.

13. The process as claimed in claim 11, wherein said mechanisms at said electrocatalyst electrode are diffusion controlled and adsorption controlled.